Stock Earnings

Question 1

How did SYRE's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Spyre Therapeutics Inc is $-0.15, not beating expectations of $-0.76.

Question 2

How did Spyre Therapeutics Inc SYRE's revenue perform in the last quarter?

Accepted Answer

Spyre Therapeutics Inc revenue for the last quarter is $-0.15

Question 3

What is the revenue estimate for Spyre Therapeutics Inc?

Accepted Answer

According to 13 of Wall street analyst, the revenue estimate of Spyre Therapeutics Inc range from $0.0 to $0.0

Question 4

What's the earning quality score for Spyre Therapeutics Inc?

Accepted Answer

Spyre Therapeutics Inc has a earning quality score of B+/55.836437. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Spyre Therapeutics Inc report earnings?

Accepted Answer

Spyre Therapeutics Inc next earnings report is expected in 2026-02-02

Question 6

What are Spyre Therapeutics Inc's expected earnings?

Accepted Answer

Spyre Therapeutics Inc expected earnings is $0.0, according to wall-street analysts.

Question 7

Did Spyre Therapeutics Inc beat earnings expectations?

Accepted Answer

Spyre Therapeutics Inc recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.76	$-0.15	-80.26%	MISSED
Q2 '25	$-0.76	$-0.77	+1.31%	BEAT
Q1 '25	$-0.85	$-0.6	-29.41%	MISSED
Q4 '24	$-1.01	$-0.81	-19.8%	MISSED
Q3 '24	$-0.84	$-1.36	+61.9%	BEAT

Spyre Therapeutics Inc (SYRE) Price

SYRE Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ